Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Palbociclib + Letrozole|DRUG: Letrozole
Sponsor: Shengjing Hospital